Table 3 Hepatic oxidative (MDA) and antioxidative (GSH and SOD) parameters in EAC-bearing mice after treatment with amygdalin and/or sorafenib.

3.98 ± 0.11^f

6.31 ± 0.16^b

58.63 ± 1.23^a

4.01 ± 0.14^f

7.22 ± 0.23^a

54.09 ± 1.99^a

4.08 ± 0.09^f

6.06 ± 0.19^b

55.28 ± 1.76^a

4.17 ± 0.17^f

6.13 ± 0.18^b

56.21 ± 2.38^a

4.12 ± 0.15^f

5.98 ± 0.14^b

54.14 ± 2.14^a

4.23 ± 0.16^f

6.04 ± 0.15^b

56.82 ± 1.77^a

23.58 ± 0.76^a

3.23 ± 0.11^e

25.26 ± 0.54^g

15.37 ± 0.43^b

4.43 ± 0.13^d

32.12 ± 0.77^f

10.50 ± 0.35^d

5.14 ± 0.14^c

39.32 ± 0.54^d

13.51 ± 0.32^c

5.03 ± 0.15^c

36.39 ± 0.42^e

7.30 ± 0.26^e

6.35 ± 0.22^b

47.05 ± 1.01^b

9.76 ± 0.36^d

5.33 ± 0.16^c

42.31 ± 0.63^c